Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
卡那单抗作为托珠单抗治疗失败后二线生物制剂治疗系统性幼年特发性关节炎患儿的疗效和安全性：一项使用常规收集的健康数据的单中心队列研究
期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2023.1114207
Alexeeva, Ekaterina; Krekhova, Elizaveta; Dvoryakovskaya, Tatyana; Isaeva, Ksenia; Chomakhidze, Aleksandra; Chistyakova, Evgeniya; Lomakina, Olga; Denisova, Rina; Mamutova, Anna; Fetisova, Anna; Gautier, Marina; Vankova, Dariya; Kriulin, Ivan; Saygitov, Ruslan
